Frigerio E, Guizelini C, Jussiani G, Marco K, de Melo G, Watanabe T
Front Vet Sci. 2023; 10:1208919.
PMID: 37781278
PMC: 10537919.
DOI: 10.3389/fvets.2023.1208919.
Pena M, Tang F, Franco F, Rodrigues A, Carrara G, Araujo T
Parasitology. 2023; 150(10):922-933.
PMID: 37553284
PMC: 10577668.
DOI: 10.1017/S0031182023000720.
Das K, Nozaki T
Int J Mol Sci. 2023; 24(13).
PMID: 37445815
PMC: 10341546.
DOI: 10.3390/ijms241310637.
Margaroni M, Agallou M, Tsanaktsidou E, Kammona O, Kiparissides C, Karagouni E
Vaccines (Basel). 2023; 11(2).
PMID: 36851182
PMC: 9960668.
DOI: 10.3390/vaccines11020304.
Esteves S, Costa I, Luelmo S, Santarem N, Cordeiro-da-Silva A
Microorganisms. 2022; 10(12).
PMID: 36557688
PMC: 9781507.
DOI: 10.3390/microorganisms10122435.
Investigating the Existence of Ribosomal Protein L5 Gene in Syrian Strain of Genome: Sequencing It and Evaluating Its Immune Response as DNA Vaccine.
Maarouf M, Abdlwahab A
J Parasitol Res. 2021; 2021:6617270.
PMID: 34094593
PMC: 8163552.
DOI: 10.1155/2021/6617270.
and Evaluation of Mimetic Peptides as Potential Antigen Candidates for Prophylaxis of Leishmaniosis.
Guedes D, Santiani M, Carvalho J, Soccol C, Minozzo J, Avila R
Front Chem. 2021; 8:601409.
PMID: 33520931
PMC: 7843434.
DOI: 10.3389/fchem.2020.601409.
More than just exosomes: distinct extracellular products potentiate the establishment of infection.
Perez-Cabezas B, Santarem N, Cecilio P, Silva C, Silvestre R, Catita J
J Extracell Vesicles. 2018; 8(1):1541708.
PMID: 30455859
PMC: 6237156.
DOI: 10.1080/20013078.2018.1541708.
Molecular characterization and protective efficacy of silent information regulator 2A from Eimeria tenella.
Dong H, Yang S, Zhao Q, Han H, Zhu S, Zhu X
Parasit Vectors. 2016; 9(1):602.
PMID: 27884171
PMC: 5123391.
DOI: 10.1186/s13071-016-1871-0.
Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.
Markikou-Ouni W, Drini S, Bahi-Jaber N, Chenik M, Meddeb-Garnaoui A
PLoS One. 2015; 10(11):e0143063.
PMID: 26581100
PMC: 4651425.
DOI: 10.1371/journal.pone.0143063.
Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
Soto M, Corvo L, Garde E, Ramirez L, Iniesta V, Bonay P
PLoS Negl Trop Dis. 2015; 9(5):e0003751.
PMID: 25955652
PMC: 4425485.
DOI: 10.1371/journal.pntd.0003751.
Apoptotic-like Leishmania exploit the host's autophagy machinery to reduce T-cell-mediated parasite elimination.
Crauwels P, Bohn R, Thomas M, Gottwalt S, Jackel F, Kramer S
Autophagy. 2015; 11(2):285-97.
PMID: 25801301
PMC: 4502818.
DOI: 10.1080/15548627.2014.998904.
Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamsters.
Pereira L, Abbehusen M, Teixeira C, Cunha J, Nascimento I, Fukutani K
PLoS Negl Trop Dis. 2015; 9(2):e0003490.
PMID: 25642946
PMC: 4313940.
DOI: 10.1371/journal.pntd.0003490.
Deception and manipulation: the arms of leishmania, a successful parasite.
Cecilio P, Perez-Cabezas B, Santarem N, Maciel J, Rodrigues V, Cordeiro da Silva A
Front Immunol. 2014; 5:480.
PMID: 25368612
PMC: 4202772.
DOI: 10.3389/fimmu.2014.00480.
Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine.
Seyed N, Taheri T, Vauchy C, Dosset M, Godet Y, Eslamifar A
PLoS One. 2014; 9(10):e108848.
PMID: 25310094
PMC: 4195657.
DOI: 10.1371/journal.pone.0108848.
Involvement of different CD4(+) T cell subsets producing granzyme B in the immune response to Leishmania major antigens.
Naouar I, Boussoffara T, Ben Ahmed M, Belhaj Hmida N, Gharbi A, Gritli S
Mediators Inflamm. 2014; 2014:636039.
PMID: 25104882
PMC: 4102068.
DOI: 10.1155/2014/636039.
The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish®) remains effective against an experimental challenge one year later.
Martin V, Vouldoukis I, Moreno J, McGahie D, Gueguen S, Cuisinier A
Vet Res. 2014; 45:69.
PMID: 24964736
PMC: 4086268.
DOI: 10.1186/1297-9716-45-69.
Identifying vaccine targets for anti-leishmanial vaccine development.
Sundar S, Singh B
Expert Rev Vaccines. 2014; 13(4):489-505.
PMID: 24606556
PMC: 4040457.
DOI: 10.1586/14760584.2014.894467.
Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis.
Carneiro M, Santos D, Fukutani K, Clarencio J, Miranda J, Brodskyn C
PLoS One. 2013; 7(12):e52296.
PMID: 23284976
PMC: 3527524.
DOI: 10.1371/journal.pone.0052296.
Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine.
Dominguez-Bernal G, Horcajo P, Orden J, De La Fuente R, Herrero-Gil A, Ordonez-Gutierrez L
Vet Res. 2012; 43:59.
PMID: 22876751
PMC: 3503552.
DOI: 10.1186/1297-9716-43-59.